{"id":1166,"date":"2020-02-04T09:43:58","date_gmt":"2020-02-04T08:43:58","guid":{"rendered":"http:\/\/haavind.local\/en\/2020\/02\/04\/pharma-report-winter-2020\/"},"modified":"2022-07-21T12:51:09","modified_gmt":"2022-07-21T12:51:09","slug":"pharma-report-winter-2020","status":"publish","type":"post","link":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/","title":{"rendered":"The Haavind Pharma Report Winter 2020"},"content":{"rendered":"\t<div class=\"template-post alignwide wp-block-dekode-hero\">\n\t\t<div class=\"hero__inner\">\n\t\t\t<div class=\"hero__inner_blocks\">\n\t\t\t\t<h1 class=\"wp-block-post-title\">The Haavind Pharma Report Winter 2020<\/h1>\n\n<p>In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div><\/div>\n\t\t\t\t\t<div class=\"post-meta\">\n\t\t\t\t\t\t<span class=\"info-small\">04 February, 2020 \u00b7 2 min. reading time<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\n<div class=\"alignleft wp-block-haavind-byline\">\n\t\t\t\t<span class=\"author-tag\">Written by<\/span>\n\t\t\t\t<div class=\"authors\"><a href=\"https:\/\/haavind.stage01.dekodes.no\/en\/people\/hakon-austdal\/\" class=\"t2-byline__author-link\">\n\t\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg\" \/>\n\t\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">H\u00e5kon Austdal<\/span>\n\t\t\t\t\t\t<span>Specialist Counsel<\/span>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a><a href=\"https:\/\/haavind.stage01.dekodes.no\/en\/people\/vebjorn-krag-iversen\/\" class=\"t2-byline__author-link\">\n\t\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2016\/04\/Vebjorn-Iversen-233x300.jpg\" \/>\n\t\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">Vebj\u00f8rn Krag Iversen<\/span>\n\t\t\t\t\t\t<span>Partner<\/span>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a><\/div>\n\t\t\t\t<div class=\"topics\">\n\t\t\t\t<span>Topics<\/span>\n\t\t\t\t<div><a class=\"tag-link\" href=\"https:\/\/haavind.stage01.dekodes.no\/en\/expertise\/dispute-resolution\">Dispute resolution<\/a><span class=\"tag-link\">Intellectual property rights<\/span><span class=\"tag-link\">Healthcare and life science<\/span><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n<p>In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n\n\n<p>Read and download the Pharma Report Winter 2020 to learn more about the proposed legislative changes to combat medicinal shortages, which have plagued Norway for several years.<\/p>\n\n\n\n<p>Also in the Report, we discuss whether so-called \u00abarrow declarations\u00bb may be used in patent cases, and the status of SPC-waivers in Norway so far. We will also cover the latest legal developments within off-label use.<a href=\"https:\/\/indd.adobe.com\/view\/c6579fd0-34b0-4bd4-90ab-52f3b520561d\"><strong>Read the Pharma Report Winter 2020 here<\/strong><\/a><\/p>\n\n\n\n<p>Haavind\u2019s Pharma Report is a retrospective report on legal developments in Norway relevant for the pharmaceutical sector. Our report is published twice a year, and focuses in particular on relevant developments within regulatory affairs and intellectual property. As with our previous reports published since 2016, we are pleased to present a retrospective view on the most significant legal developments that occurred during the second half of 2019.<a href=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2020\/02\/Advokatfirmaet-Haavind-Pharma-Report-Winter-2020.pdf?utm_source=Web&amp;utm_campaign=Life%20Sciences\"><strong>Download the Pharma Report Winter 2020 here<\/strong><\/a><\/p>\n\n\n<div class=\"wp-block-image\"><figure class=\"alignleft\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1810\" src=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg\" alt=\"Haavind Pharma Report Winter\" class=\"wp-image-1941\" title=\"Haavind Pharma Report Winter\" srcset=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg 2560w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-300x212.jpg 300w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-1024x724.jpg 1024w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-768x543.jpg 768w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-1536x1086.jpg 1536w, https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-2048x1448.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/><figcaption>Haavind Pharma Report Winter<\/figcaption><\/figure><\/div>\n\n\n<p><em>Haavind\u2019s Health and Life Science team continuously and closely monitors developments in Norway relevant to the pharma sector. If you wish to discuss how your business can best meet the legal challenges of this innovative and highly regulated sector, you are always welcome to contact us.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.<\/p>\n","protected":false},"author":0,"featured_media":1941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"sector":[7],"speciality":[17,24],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.2 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Haavind Pharma Report Winter 2020 - Haavind EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Haavind Pharma Report Winter 2020\" \/>\n<meta property=\"og:description\" content=\"In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Haavind EN\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-04T08:43:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-21T12:51:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1810\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/\",\"name\":\"The Haavind Pharma Report Winter 2020 - Haavind EN\",\"isPartOf\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg\",\"datePublished\":\"2020-02-04T08:43:58+00:00\",\"dateModified\":\"2022-07-21T12:51:09+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg\",\"contentUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg\",\"width\":2560,\"height\":1810,\"caption\":\"Haavind Pharma Report Winter\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Dispute resolution\",\"item\":\"https:\/\/haavind.stage01.dekodes.no\/en\/kompetanse\/fagomrade\/dispute-resolution\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Haavind Pharma Report Winter 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/\",\"name\":\"Haavind EN\",\"description\":\"-\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The Haavind Pharma Report Winter 2020 - Haavind EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/","og_locale":"en_US","og_type":"article","og_title":"The Haavind Pharma Report Winter 2020","og_description":"In the Pharma Report Winter 2020, we take a retrospective look at some of the legal developments during the second half of 2019 in the Norwegian pharmaceutical sector.","og_url":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/","og_site_name":"Haavind EN","article_published_time":"2020-02-04T08:43:58+00:00","article_modified_time":"2022-07-21T12:51:09+00:00","og_image":[{"width":2560,"height":1810,"url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/","url":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/","name":"The Haavind Pharma Report Winter 2020 - Haavind EN","isPartOf":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage"},"image":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg","datePublished":"2020-02-04T08:43:58+00:00","dateModified":"2022-07-21T12:51:09+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#primaryimage","url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg","contentUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/petriskal-krukke-scaled.jpg","width":2560,"height":1810,"caption":"Haavind Pharma Report Winter"},{"@type":"BreadcrumbList","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/pharma-report-winter-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Dispute resolution","item":"https:\/\/haavind.stage01.dekodes.no\/en\/kompetanse\/fagomrade\/dispute-resolution\/"},{"@type":"ListItem","position":2,"name":"The Haavind Pharma Report Winter 2020"}]},{"@type":"WebSite","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website","url":"https:\/\/haavind.stage01.dekodes.no\/en\/","name":"Haavind EN","description":"-","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1166"}],"collection":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/comments?post=1166"}],"version-history":[{"count":1,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1166\/revisions"}],"predecessor-version":[{"id":3719,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1166\/revisions\/3719"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media\/1941"}],"wp:attachment":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media?parent=1166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/categories?post=1166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/tags?post=1166"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/sector?post=1166"},{"taxonomy":"speciality","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/speciality?post=1166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}